Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Derek WongAnalyst, Digital Health
Derek Wong joined Burrill & Company in 2011 as an Analyst in the Digital Health Practice. He was instrumental in the Series A investment in AliveCor, the iPhone & Android ECG company. Prior to Burrill & Company, he taught physics at the University of San Francisco. He was a member of the QB3 New Venture Consulting Group at the California Institute of Quantitative Biology (QB3) and assisted spin-outs from the University of California in commercializing their technologies. Mr. Wong participated in the Management of Technology Program at U.C. Berkeley’s Haas School of Business where he worked on various projects including electric vehicle deployment and computer user interface redesign for young children. Trained as an engineer and a scientist, Mr. Wong has co-authored several research articles published in top-tier scientific journals including Cell and Physical Review Letters. Derek holds a Ph.D. in Bioengineering from the University of California, Berkeley and San Francisco, a B.S.E. from the University of Pennsylvania, and a B.S. from Haverford College.